Additional file 2: of Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment Nathan Ungerleider Sonia Rao Ashkan Shahbandi Douglas Yee Tianhua Niu Wesley Frey James Jackson 10.6084/m9.figshare.7155671.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_Breast_cancer_survival_predicted_by_TP53_mutation_status_differs_markedly_depending_on_treatment/7155671 Figure S1 Overall survival curves by PAM50 classification (for A-F) all patients from METABRIC cohort; (G-L) hormone therapy-treated patients. PAM50 classification was already determined in the METABRIC cohort and accessed through cBioportal. (PDF 1142 kb) 2018-10-01 05:00:00 TP53 Breast cancer Chemotherapy Hormone therapy Survival Senescence